ICMR releases plan, vision for 2030

Image
Press Trust of India New Delhi
Last Updated : Oct 11 2017 | 9:28 PM IST
The Indian Council of Medical Research (ICMR) today released its 'Strategic Plan and Vision 2030' which outlines the body's agenda to deal with health challenges in the country.
The agenda is based on key points such as capacity building, data management, leveraging traditional medicine and strengthening programme implementation through research, a statement issued by the ICMR said.
It aims at combating non-communicable diseases and improving maternal and child health in India, it said.
The research body in collaboration with the Health Ministry has awarded 86 scientists for finding solutions to important health challenges and for their contribution in bio-medical science research, the statement said.
In an effort to encourage youngsters to join health research and choose it as a preferred career, 'Short Term Studentship Excellence' awards were also presented for the first time this year, it said.
The council today also released the National Guidelines for Stem Cell Research 2017 for all stakeholders including individual and organisations associated with basic and clinical research on stem cells and their derivatives.
The guidelines have been revised to ensure that while giving an impetus to research, it does not compromise on the safety of patients and vulnerable individuals, the statement said.
"The 2017 guidelines, reiterate that any stem cell use in patients, other than that for hematopoietic stem cell reconstitution for approved indications, is investigational at present.
"Accordingly, any stem cell use in patients must only be done within the purview of an approved and monitored clinical trial. In accordance with this stringent definition, every use of stem cells in patients outside an approved clinical trial is unethical and shall be considered as malpractice," the statement said.
Responsible research must focus on harnessing the potential of science to improve our understanding of human health and illness, as well as discover newer ways to prevent and treat them, it said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 11 2017 | 9:28 PM IST

Next Story